Breast carcinoma vascularity: A comparison of manual microvessel count and Chalkley count

Histology and Histopathology

Volumn 24, Issue 8, 2009, Pages 1049-1059

  Dhakal, Hari Prasad ^a   Bassarova, Assia ^a   Naume, Bjørn ^a   Synnestvedt, Marit ^a   Borgen, Elin ^a   Kaaresen, Rolf ^b   Schlichting, Ellen ^b   Wiedswang, Gro ^b   Giercksky, Karl Erik ^a   Nesland, Jahn M ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Breast; Carcinoma; Chalkley; MVD; Vascularity

Indexed keywords

ARTICLE; BLOOD VESSEL; BREAST TUMOR; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LUNG CARCINOMA; METASTASIS; MORTALITY; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION (PATHOLOGY); PAGET NIPPLE DISEASE; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; SURVIVAL RATE; TIME; TUMOR RECURRENCE; VASCULARIZATION;

BLOOD VESSELS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOVASCULARIZATION, PATHOLOGIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL RATE; TIME FACTORS;

EID: 69149099170     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Axelsson K., Ljung B.M., Moore D.H. II, Thor A.D., Chew K.L., Edgerton S.M., Smith H.S. and Mayall B.H. (1995). Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J. Natl. Cancer Inst. 87, 997-1008.
2. Bosari S., Lee A.K., DeLellis R.A., Wiley B.D., Heatley G.J. and Silverman M.L. (1992). Microvessel quantification and prognosis in invasive breast carcinoma. Hum. Pathol. 23, 755-61.
3. Clahsen P.C., van de Velde C.J., Duval C., Pallud C., Mandard A.M., Delobelle-Deroide A., van den Broek L., Sahmoud T.M. and van de Vijver M.J. (1998). p53 protein accumulation and response to adjuvant chemotherapy in premenopausal women with nodenegative early breast cancer. J. Clin. Oncol. 16, 470-479.
4. Costello P., McCann A., Carney D.N. and Dervan P.A. (1995). Prognostic significance of microvessel density in lymph node negative breast carcinoma. Hum. Pathol. 26, 1181-1184.
5. de Jong J.S., van Diest P.J. and Baak J.P. (2000). Hot spot microvessel density and the mitotic activity index are strong additional prognostic indicators in invasive breast cancer. Histopathology 36, 306-312.
6. Dhakal H.P., Naume B., Synnestvedt M., Borgen E., Kaaresen R., Schlichting E., Wiedswang G., Bassarova A., Giercksky K.E. and Nesland J.M. (2008). Vascularization in primary breast carcinomas: its prognostic significance and relationship with tumor cell dissemination. Clin. Cancer Res. 14, 2341-2350.
7. Ellis I.O., Schnitt S.J., Sastre-Garau X., Bussolati G., Tavassoli F.A., Eusebi V., Peterse J.L., Mukai K., Tabar L., Jacquemier J., Cornelisse C.J., Sasco A.J., Kaaks R., Pisani P., Goldgar D.E., Devilee P., Cleton-Jansen M.J., Børresen-Dale A.L., van't Veer L. and Sapino A. (2003). Invasive breast carcinoma. In: World Health Organization Classification of Tumours Pathology and Genetics. Tumours of the Breast and Female Genital Organs. Tavassoli F.A. and Devilee P. (eds). IARC Press. Lyon, France. pp 13-59.
8. Elston C.W. and Ellis I.O. (1991). Pathological prognostic factors in breast cancer I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19, 403-410.
9. Folkman J. (1990) What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. 82, 4-6.
10. Fox S.B., Gatter K.C., Leek R.D., Harris A.L., Chew K.L., Mayall B.H. and Moore D.H. (2000). More about: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J. Natl. Cancer Inst. 92, 161-162.
11. Fox S.B. and Harris A.L. (2004). Histological quantitation of tumour angiogenesis. APMIS 112, 413-430.
12. Fox S.B., Leek R.D., Smith K., Hollyer J., Greenall M. and Harris A.L. (1994). Tumor angiogenesis in node-negative breast carcinomas-- relationship with epidermal growth factor receptor, estrogen receptor, and survival. Breast Cancer Res. Treat. 29, 109-116.
13. Fox S.B., Leek R.D., Weekes M.P., Whitehouse R.M., Gatter K.C. and Harris A.L. (1995a). Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J. Pathol. 177, 275-283.
14. Fox S.B., Turner G.D., Leek R.D., Whitehouse R.M., Gatter K.C. and Harris A.L. (1995b). The prognostic value of quantitative angiogenesis in breast cancer and role of adhesion molecule expression in tumor endothelium. Breast Cancer Res.Treat. 36, 219-226.
15. Fox S.B., Taylor M., Grondahl-Hansen J., Kakolyris S., Gatter K.C. and Harris A.L. (2001). Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer. J. Pathol. 195, 236-243.
16. Fridman V., Humblet C., Bonjean K. and Boniver J. (2000). Assessment of tumor angiogenesis in invasive breast carcinomas: absence of correlation with prognosis and pathological factors. Virchows Arch. 437, 611-617.
17. Gasparini G., Weidner N., Bevilacqua P., Maluta S., Dalla Palma P., Caffo O., Barbareschi M., Boracchi P., Marubini E. and Pozza F. (1994). Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J. Clin. Oncol.12, 454-466.
18. Gasparini G., Toi M., Verderio P., Ranieri G., Dante S., Bonoldi E., Boracchi P., Fanelli M. and Tominaga T. (1998). Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and nodenegative patients. Int. J. Oncol. 12, 1117-1125.
19. Goffin J.R., Straume O., Chappuis P.O., Brunet J.S., Begin L.R., Hamel N., Wong N., Akslen L.A. and Foulkes W.D. (2003). Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer. Br. J. Cancer 89, 1031-1034.
20. Goulding H., Abdul Rashid N.F., Robertson J.F., Bell J.A., Elston C.W., Blamey R.W. and Ellis I.O. (1995). Assessment of angiogenesis in breast carcinoma: an important factor in prognosis?. Hum. Pathol. 26, 1196-1200.
21. Guidi A.J., Berry D.A., Broadwater G., Perloff M., Norton L., Barcos M.P. and Hayes D.F. (2000). Association of angiogenesis in lymph node metastases with outcome of breast cancer. J. Natl. Cancer Inst. 92, 486-492.
22. Hansen S., Grabau D.A., Rose C., Bak M. and Sorensen F.B. (1998). Angiogenesis in breast cancer: a comparative study of the observer variability of methods for determining microvessel density. Lab. Invest. 78, 1563-1573.
23. Hansen S., Grabau D.A., Sorensen F.B., Bak M., Vach W. and Rose C. (2000a). The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients. Clin. Cancer Res. 6, 139-146.
24. Hansen S., Grabau D.A., Sorensen F.B., Bak M., Vach W. and Rose C. (2000b). Vascular grading of angiogenesis: prognostic significance in breast cancer. Br. J. Cancer 82, 339-347.
25. Hansen S., Sorensen F.B., Vach W., Grabau D.A., Bak M. and Rose C. (2004). Microvessel density compared with the Chalkley count in a prognostic study of angiogenesis in breast cancer patients. Histopathology 44, 428-436.
26. Heimann R., Ferguson D., Gray S. and Hellman S. (1998). Assessment of intratumoral vascularization (angiogenesis) in breast cancer prognosis. Breast Cancer Res. Treat. 52, 147-158.
27. Koukourakis M.I., Manolas C., Minopoulos G., Giatromanolaki A. and Sivridis E. (2003). Angiogenesis relates to estrogen receptor negativity, c-erbB-2 overexpression and early relapse in nodenegative ductal carcinoma of the breast. Int. J. Surg. Pathol. 11, 29-34.
28. Lipponen P., Ji H., Aaltomaa S. and Syrjanen K. (1994). Tumour vascularity and basement membrane structure in breast cancer as related to tumour histology and prognosis. J. Cancer Res. Clin. Oncol. 120, 645-650.
29. Ludovini V., Sidoni A., Pistola L., Bellezza G., De Angelis V., Gori S., Mosconi A.M., Bisagni G., Cherubini R., Bian A.R., Rodino C., Sabbatini R., Mazzocchi B., Bucciarelli E., Tonato M. and Colozza M. (2003). Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages I and II breast cancer patients. Breast Cancer Res. Treat. 81, 159-168.
30. Martin L., Green B., Renshaw C., Lowe D., Rudland P., Leinster S.J. and Winstanley J. (1997). Examining the technique of angiogenesis assessment in invasive breast cancer. Br. J. Cancer 76, 1046-1054.
31. Naume B., Borgen E., Kvalheim G., Karesen R., Qvist H., Sauer T., Kumar T. and Nesland J.M. (2001). Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics. Clin. Cancer Res. 7, 4122-4129.
32. Naume B., Wiedswang G., Borgen E., Kvalheim G., Karesen R., Qvist H., Janbu J., Harbitz T. and Nesland J.M. (2004). The prognostic value of isolated tumor cells in bone marrow in breast cancer patients: evaluation of morphological categories and the number of clinically significant cells. Clin. Cancer Res. 10, 3091-3097.
33. Offersen B.V., Borre M. and Overgaard J. (2003). Quantification of angiogenesis as a prognostic marker in human carcinomas: a critical evaluation of histopathological methods for estimation of vascular density. Eur. J. Cancer 39, 881-890.
34. Offersen B.V., Sorensen F.B., Yilmaz M., Knoop A. and Overgaard J. (2002). Chalkley estimates of angiogenesis in early breast cancer--relevance to prognosis. Acta Oncol. 41, 695-703.
35. Toi M., Inada K., Suzuki H. and Tominaga T. (1995). Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res. Treat. 36, 193-204.
36. Tsutsui S., Yasuda K., Suzuki K., Tahara K., Higashi H. and Era S. (2005). Macrophage infiltration and its prognostic implications in breast cancer: The relationship with VEGF expression and microvessel density. Oncol. Rep. 14, 425-431.
37. Uzzan B., Nicolas P., Cucherat M. and Perret G.Y. (2004). Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. Cancer Res. 64, 2941-2955.
38. Van Hoef M.E., Knox W.F., Dhesi S.S., Howell A. and Schor A.M. (1993). Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur. J. Cancer 29A, 1141-1145.
39. Vermeulen P.B., Gasparini G., Fox S.B., Colpaert C., Marson L.P., Gion M., Belien J.A., de Waal R.M., Van Marck E., Magnani E., Weidner N., Harris A.L. and Dirix L.Y. (2002). Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur. J. Cancer 38, 1564-1579.
40. Vermeulen P.B., Libura M., Libura J., O'Neill P.J., Van Dam P., Van Marck E., Van Oosterom A.T. and Dirix L.Y. (1997). Influence of investigator experience and microscopic field size on microvessel density in node-negative breast carcinoma. Breast Cancer Res. Treat. 42, 165-172.
41. Vincent-Salomon A., Carton M., Zafrani B., Freneaux P., Nicolas A., Massemin B., Fourquet A., Clough K., Pouillart P. and Sastre-Garau X. (2001). Long term outcome of small size invasive breast carcinomas independent from angiogenesis in a series of 685 cases. Cancer 92, 249-256.
42. Weidner N., Folkman J., Pozza F., Bevilacqua P., Allred E.N., Moore D.H., Meli S. and Gasparini G. (1992). Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst. 84, 1875-1887.
43. Weidner N., Semple J.P., Welch W.R. and Folkman J. (1991). Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N. Engl. J. Med. 324, 1-8.
44. Wiedswang G., Borgen E., Karesen R., Kvalheim G., Nesland J.M., Qvist H., Schlichting E., Sauer T., Janbu J., Harbitz T. and Naume B. (2003). Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. J. Clin. Oncol. 21, 3469-3478.